Explore
Management of Sepsis: What's New in 2024?

Management of Sepsis: What’s New in 2024?

September 12, 2024
84 Views
0

Sepsis is a clinical syndrome resulting from a dysregulated host response to infection with a severity that ranges from sepsis to septic shock results in life-threatening organ dysfunction. Septic shock represents the most severe form of sepsis, which is characterized by significant drop in systolic blood pressure, with reducing tissue perfusion pressure and leads to the hypoxia typical of shock.

Mortality rates vary but are estimated at >10% for sepsis and > 40% when septic shock is present. This blog covers the management of sepsis and septic shock following guidelines that are largely aligned with established protocols.

 

Immediate Evaluation and Management of Sepsis

Managing patients with sepsis and septic shock, it is important to secure the airway, address hypoxemia, and establish venous access promptly to begin administering and antibiotics.

Key steps in the management of sepsis are undertaken simultaneously where possible and comprise:

 

Resuscitation

The standard airway, breathing and circulation approach to resuscitation is undertaken. Bundles of care are defined by the Surviving Sepsis Campaign.

 

Airway and Breathing

Immediate intubation and ventilation may be necessary where there is airway obstruction, respiratory failure or impaired consciousness. Extreme care is required when intubating a septic patient because induction of anaesthesia may induce profound hypotension and even cardiac arrest. After intubation, a lung protective ventilation strategy is used.

 

Circulation

Management of circulation is the immediate priority at presentation. Check heart rate and blood pressure. Perfusion can be impaired in the absence of hypotension and is assessed as follows:

  • Clinical signs such as capillary refill time or mental confusion.
  • Urine output-measured hourly.
  • Lactate- measured by blood gas analysers from an arterial, venous or capillary blood sample. Elevated lactate may reflect anaerobic metabolism due to inadequate oxygen delivery to the tissues (exacerbated if there is reduced lactate clearance by the liver).
  • Sample is taken from Central Venous Catheter (CVC) to evaluate in a blood gas analyser.
Surviving Sepsis Campaign Proposes Two Bundles
To be completed within 3 hours
  • Measuring plasma lactate level
  • Obtain blood samples before administration of antibiotics
  • Administer broad spectrum antibiotics
  • Administer 30 mL Kg -1 crystalloid for hypotension
To be completed within 6 hours
  • Infuse vasopressors to maintain a mean arterial pressure 65 mmHG
  • Measure central venous pressure (target > 8 mmHg)
  • Measure venous oxygen saturation (target > 70%)
  • Re-measure lactate if initial lactate was elevated (Normalization of lactate)
  • Specific devices used to assess the adequacy of intravascular volume replacement and cardiac output.

 

Fluid Therapy

Fluid is the management of sepsis, helps to restore and maintain adequate tissue perfusion and oxygen delivery to organs.

  1. Restore Perfusion: Patient experience hypotension and hypoperfusion due to vasodilation and capillary leakage, fluids help to improve blood pressure and increase cardiac output.
  2. Correct Hypovolemia: Sepsis leads to fluid loss from blood vessels into tissues and fluid therapy replenishes this loss.
  3. Optimize Organ Function: Adequate fluid resuscitation therapy ensures vital organs like the heart, kidneys, and brain receive enough blood and oxygen.

 

Types of Fluids

Crystalloids
  • For Initial Resuscitation: Normal Saline (0.9%), Lactated Ringer’s to avoid hyperchloremic acidosis associated with large volumes of saline.
  • Dose: Surviving Sepsis Campaign recommends starting with a bolus of 30 mL/kg of crystalloid within the first 3 hours for septic shock or severe sepsis with hypotension or lactate> 4mmol/L.
Colloids
  • Include solutions like albumin, not typically recommended as first line. Used if large amounts of crystalloids are needed.
Monitoring and Adjusting Fluid Therapy
  • Dynamic Variables: Use measures like stroke volume, pulse pressure variation, or ultrasound to assess fluid responsiveness.
  • Physical Examination: Examine for signs of improved perfusion (capillary refill, urine output, skin mottling).
  • Hemodynamic Goals: Aim for a mean arterial pressure (MAP) of >65mmHg and adequate urine output (0.5 mL/kg/h).
Potential Risks
  • Excessive fluids cause pulmonary edema, abdominal compartment syndrome and worsen outcomes.
  • Inadequate fluid resuscitation can lead to persistent hypoperfusion and organ failure.

In recent guidelines mentioned, early and aggressive fluid resuscitation is emphasized, there’ also a shift towards early de-escalation of fluids once stabilization is achieved, especially in Intensive care unit settings.

 

Vasoactive Drugs

Vasoactive drugs used in sepsis management:

Norepinephrine (Levophed)
  • First-line vasopressor in septic shock.
  • Works mainly on alpha-1 adrenergic receptors to cause vasoconstriction and increase blood pressure.
  • Low effect on heart rate, respiratory rate making it less likely to induce arrhythmias.
Vasopressin
  • Second-line agent in conjunction with norepinephrine.
  • Acts on V1 receptors to cause vasoconstriction and helps to reduce the dose of norepinephrine required.
  • Particularly useful in patients with septic shock who are resistant to norepinephrine.
Epinephrine (Adrenaline)
  • Typically used when there is a need for both inotropic and vasopressor support.
  • It stimulates both alpha and beta receptors, increasing cardiac output and peripheral resistance.
  • It is generally used as a second-line agent after norepinephrine.
Dobutamine
  • Primarily an inotropic agent that enhances myocardial contractility.
  • Used when there is myocardial dysfunction (decreased cardiac output) despite adequate fluid resuscitation.
  • It does not have strong vasoconstrictive properties, so it is often combined with a vasopressor if hypotension persists.

 

Diagnosis of Sepsis

With thorough history and examination, looking for symptoms (e.g. productive cough) and signs like pyrexia or rash, which may suggest the presence of sepsis in patient and the likely primary site of infection.

Target investigations include laboratory tests and radiological imaging to give information on the site of infection.

The initial diagnosis of sepsis CRP may have a role in assessing resolution of infection or failure of therapy by following trends in levels.

Samples for microbiological culture are taken from all potential sites of infection before antibiotic administration when possible, including sputum, urine, CSF and pus depending on clinical presentation.

 

Antibiotic Administration for Sepsis

Delay between presentation and administration of antibiotics in sepsis will increase mortality.

Antibiotic administration given immediately after cultures have been taken, within one hour of presentation.

General principle is to initiate therapy with broad spectrum agents chosen depending on site of infection, local antibiotic sensitivity patterns, tissue penetration and patient factor such as renal dysfunction.

Results of cultures will enable narrowing of the spectrum of antibiotic therapy, reducing the selection of drug-resistant species such as MRSA and clostridium difficile.

 

Frequently Asked Questions (FAQs)

Q1. What is the sepsis 6 protocols?

Ans. A set of six tasks including oxygen, cultures, antibiotics, fluids, lactate measurement and urine output monitoring- to be instituted within one hour by non-specialist practitioners at the frontline.

 

Q2. What is the 3-hour protocol for patients with sepsis?

Ans. Four 3-hour SSC guideline recommendations: 1) obtain blood culture before antibiotics, 2) obtain lactate level, 3) administer broad-spectrum antibiotics, and 4) 30 mL/kg of crystalloid fluid administration for hypotension (defined as mean arterial pressure (MAP) < 65) or lactate (> 4).Four 3-hour SSC guideline recommendations: 1) obtain blood culture before antibiotics, 2) obtain lactate level, 3) administer broad-spectrum antibiotics, and 4) 30 mL/kg of crystalloid fluid administration for hypotension (defined as mean arterial pressure (MAP) < 65) or lactate (> 4).

 

Q3. What is the new treatment for sepsis?

Ans. Drotrecogin alfa (activated) is a new therapeutic agent approved for reduction of mortality in adult patients with severe sepsis or septic shock.

 

Q5. What fluids are best for sepsis?

Ans. Balanced crystalloids are the fluid of first choice for sepsis resuscitation based on ready availability and taking medication costs into account. Use of 0.9% saline compared to a balanced crystalloid, such as lactated Ringer’s or PlasmaLyte, produces more kidney dysfunction and with a greater risk of dying.

 

Q6. What is the antimicrobial therapy for sepsis?

Ans. Preferred empiric monotherapy treatment of sepsis includes meropenem, imipenem, piperacillin-tazobactam, or tigecycline. Empiric combination therapy includes metronidazole plus levofloxacin, aztreonam, or a third- or fourth-generation cephalosporin.